- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03783858
Image Collection of Normal Eyes for Development of an EU RDB
Image Collection of Normal Eyes on the Optos P200TE for Development of an EU Reference Database
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
England
-
Bedford, England, United Kingdom, MK40 2SR
- Simon Browning Optometrist
-
London, England, United Kingdom, W1G 7LA
- London Vision Clinic
-
London, England, United Kingdom, NW11 7EL
- Barnard Levit Optometrists
-
-
Northern Ireland
-
Belfast, Northern Ireland, United Kingdom, BT7 1NN
- Queens University
-
-
Scotland
-
Edinburgh, Scotland, United Kingdom, EH3 6SW
- Cameron Optometry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject 22 years of age or older on the date of informed consent
- Subject able to understand the written informed consent and willing to participate as evidenced by signing the informed consent
- Subject presenting at the site with normal eyes* (Cataracts and LASIK and PRK are allowed)
- BCVA 20/40 or better (each eye)
- Subject is able to comply with the study procedures in the view of the investigator *Normal eyes are defined as eyes judged normal for the subjects age as determined by the PI or sub-investigator
Exclusion Criteria:
1.1. Subject unable to tolerate ophthalmic imaging 2. Subject with ocular media not sufficiently clear to obtain acceptable OCT images 3. History of leukemia, dementia or multiple sclerosis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Single
|
OCT images
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Retinal thickness
Time Frame: 1 day
|
In general, descriptive statistics (n, mean, standard deviation, median, minimum and maximum) and 95% confidence interval for the mean will be used to summarize each scan parameters. The 1st, 5th, 95th and 99th percentile results will be tabulated. All percentile results will be incorporated in the device software. |
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tunde Peto, PhD, Queens University Belfast
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- OPT1030
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on P200TE
-
Optos, PLCTerminated
-
Optos, PLCRecruiting
-
Optos, PLCCompleted
-
Optos, PLCCompleted
-
Optos, PLCOptos, Inc.UnknownGlaucoma | Retinal DiseaseUnited States